Sector Watch: Healthcare - Oct 02 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $120.37 -0.80 -0.66% | XBI: $93.20 -1.39 -1.47% | Updated Oct 02, 2018 04:26 PM
HEALTHCARE STOCKS - TOP GAINERS | ||||
---|---|---|---|---|
ATRS Antares Pharma $593.5M |
3.77+0.51 11.3 M 7.3x |
16% | ||
INO Inovio Pharmaceuticals $559.1M |
6.11+0.76 4.7 M 4.6x |
14% | ||
TRVN52WH Trevena $202.4M |
2.66+0.31 8.3 M 3.7x |
13% | ||
INCR52WH INC Research Holdings $251.7M |
306.00+31.00 4.6 M 1.9x |
11% | ||
OMER Omeros $747.3M |
15.39+1.43 4.9 M 6.3x |
10% |
HEALTHCARE STOCKS - TOP LOSERS | ||||
---|---|---|---|---|
MESO Mesoblast $972.0M |
7.07-1.53 373.7 K 4.1x |
-18% | ||
VRX52WH Valeant Pharmaceuticals International $55.1M |
0.15-0.02 5.9 M 4.7x |
-14% | ||
ADRO Aduro Biotech $493.7M |
6.25-0.93 713.1 K 1.8x |
-13% | ||
ACRX AcelRx Pharmaceuticals $204.8M |
3.38-0.44 5.9 M 6.9x |
-12% | ||
CVRS Corindus Vascular Robotics $228.6M |
1.21-0.14 1.5 M 1.8x |
-11% |
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Major Cancer Journal Highlights Data From An Inovio-Sponsored Trial In Which A Patient Achieved Full Remission After Dosing With DNA Immunotherapy and Checkpoint Inhibitor [globenewswire.com]Trial Results of Mesoblast Cell Therapy in End-Stage Heart Failure Selected as Late-Breaking Presentation at 2018 American Heart Association Scientific Sessions Australian Stock Exchange:MSB.AX [globenewswire.com]
Omeros Corporation Announces Additional Positive Data for OMS721 in IgA Nephropathy | Business Wire [businesswire.com]
Aduro Biotech Announces Four Abstracts Accepted for Presentation at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting [globenewswire.com]
Omeros Corporation Announces Reinstatement of Pass-Through Status for OMIDRIA® | Business Wire [businesswire.com]
Trevena announces completion of leadership transition and appointment of new director [globenewswire.com]
Antares Receives FDA Approval of Xyosted? (Testosterone Enanthate) Injection for Testosterone Replacement Therapy in Adult Males [globenewswire.com]
Omeros Corporation Announces Additional Positive Data for OMS721 in IgA Nephropathy | Business & Finance | manchestertimes.com [businesswire.com]
Male Hypogonadism - Pipeline Review, H2 2018 - ResearchAndMarkets.com | Business Wire [businesswire.com]
Omeros to Present at the 2018 Cantor Global Healthcare Conference | Business Wire [businesswire.com]
Alcohol Addiction Pipeline Review, H2 2018 - Therapeutic Assessment of 30 Companies - ResearchAndMarkets.com | Business Wire [businesswire.com]
Restless Legs Syndrome Pipeline Review, H2 2018 - Therapeutic Assessment of 6 Companies - ResearchAndMarkets.com | Business Wire [businesswire.com]
Global Post-Operative Pain Pipeline Review, H2 2018 - Therapeutic Assessment of 40 Companies - ResearchAndMarkets.com | Business Wire [businesswire.com]
Drug Addiction Pipeline Review, H2 2018 - Therapeutic Assessment of 25 Companies & Drug Profile Activity - ResearchAndMarkets.com | Business Wire [businesswire.com]
Left Ventricular Dysfunction Pipeline Review, H2 2018 - Therapeutics Assessment of 6 Companies & Drug Profiles - ResearchAndMarkets.com | Business Wire [businesswire.com]
Autism - Pipeline Review, H2 2018 - Therapeutic Analysis of 22 Companies & Drug Profiles - ResearchAndMarkets.com | Business Wire [businesswire.com]
Aduro Biotech to Present at Two Investor Conferences in October [globenewswire.com]
Progenics Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference [globenewswire.com]
Antares Pharma to Present at the Ladenburg Thalmann 2018 Healthcare Conference [globenewswire.com]
AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences in October | Business & Finance | manchestertimes.com [prnewswire.com]
AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences in October [prnewswire.com]
Corindus Announces First Live Transmission of Remote Robotic Demonstration Performed at Transcatheter Cardiovascular Therapeutics 2018 Conference | Business Wire [businesswire.com]
Aberdeen Income Credit Strategies Fund(1) Announces Performance Data And Portfolio Composition [prnewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.